GILEAD SCIENCES, INC. Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Tax (Deprecated 2013-01-31)
GILEAD SCIENCES, INC. (GILD) reported Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Tax (Deprecated 2013-01-31) of -$9.00 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-08.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax · last filed 2013-05-08
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, tax (deprecated 2013-01-31) for the quarter ending 2013-03-31 was -$9.00K.
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, tax (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $0.00.
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, tax (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $1.40M.
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, tax (deprecated 2013-01-31) for the quarter ending 2012-06-30 was -$29.00K.
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, tax (deprecated 2013-01-31) for fiscal 2012 was $849.00K.
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, tax (deprecated 2013-01-31) for fiscal 2011 was -$11.11M.
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, tax (deprecated 2013-01-31) for fiscal 2010 was -$3.17M.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Tax (Deprecated 2013-01-31) 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Tax (Deprecated 2013-01-31) 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Tax (Deprecated 2013-01-31) 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Tax (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-03-31 | -$9.00K 10-Q · filed 2013-05-08 | -$9.00K derived: sum of 2 quarters · filed 2013-05-08 | $1.39M derived: sum of 3 quarters · filed 2013-05-08 | $1.36M derived: sum of 4 quarters · filed 2013-05-08 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $1.40M derived: sum of 2 quarters · filed 2013-02-27 | $1.37M derived: sum of 3 quarters · filed 2013-02-27 | $849.00K 10-K · filed 2013-02-27 |
| 2012-09-30 | $1.40M 10-Q · filed 2012-11-06 | $1.37M derived: sum of 2 quarters · filed 2012-11-06 | $849.00K 10-Q · filed 2012-11-06 | -$6.06M derived: sum of 4 quarters · filed 2013-05-08 |
| 2012-06-30 | -$29.00K 10-Q · filed 2012-08-01 | -$547.00K 10-Q · filed 2012-08-01 | -$7.46M derived: sum of 3 quarters · filed 2013-05-08 | -$8.99M derived: sum of 4 quarters · filed 2013-05-08 |
| 2012-03-31 | -$519.00K 10-Q · filed 2013-05-08 | -$7.43M derived: sum of 2 quarters · filed 2013-05-08 | -$8.96M derived: sum of 3 quarters · filed 2013-05-08 | -$10.73M derived: sum of 4 quarters · filed 2013-05-08 |
| 2011-12-31 | -$6.91M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$8.44M derived: sum of 2 quarters · filed 2013-02-27 | -$10.22M derived: sum of 3 quarters · filed 2013-02-27 | -$11.11M 10-K · filed 2013-02-27 |
| 2011-09-30 | -$1.53M 10-Q · filed 2012-11-06 | -$3.31M derived: sum of 2 quarters · filed 2012-11-06 | -$4.20M 10-Q · filed 2012-11-06 | |
| 2011-06-30 | -$1.77M 10-Q · filed 2012-08-01 | -$2.61M 10-Q · filed 2012-08-01 | ||
| 2010-12-31 | -$3.17M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |